This study is in progress, not accepting new patients

FostrSpace-CASA R61/R33

a study on Substance Abuse

Summary

Eligibility
for people ages 13-20 (full criteria)
Healthy Volunteers
healthy people welcome
Location
at San Francisco, California
Dates
study started
study ends around
Principal Investigator
by Marina Tolou-Shams, PhD

Description

Summary

The purpose of this study is to understand how an online digital health application (app) called FostrSpace can reduce substance use among youth (ages 13-20 years old) in foster care.

Official Title

CASA and FostrSpace: Systems Delivery of Digital Substance Use Prevention Tools to Foster Youth

Details

The goal of this clinical trial is to identify gaps in substance use prevention across existing CASA trainings and the FostrSpace app for foster youth and test how substance use trainings for CASA volunteers could help facilitate FostrSace app referrals to reduce and prevent substance use among CASA youth.

Keywords

Substance Use, Foster youth, mHealth, Substance-Related Disorders, ECHO-FostrSpace, Informational Session, InfoECHO, InfoOnly

Eligibility

You can join if…

Open to people ages 13-20

  • Adolescents and young adults will be eligible if they are age 13-20, are proficient in English, have an assigned CASA worker, and have a device with web access.
  • CASAs (ages 18 and over) will be eligible if they are assigned to a youth between the ages of 13- 20.

You CAN'T join if...

  • Youth: Exclusion criteria include being non-English speaking, being within 3 months of ending with CASA services, cognitive impairment that precludes ability to provide informed consent.
  • CASA: Exclusion criteria include being non-English speaking and working with a youth who is within 3 months of ending with CASA services.

Location

  • UCSF Zuckerberg San Francisco General Hospital
    San Francisco California 94131 United States

Lead Scientist at UCSF

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06875323
Study Type
Interventional
Participants
Expecting 400 study participants
Last Updated